288 related articles for article (PubMed ID: 17439382)
1. Carotid artery intima-media thickness after raloxifene treatment.
Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene slows down the progression of intima-media thickness in postmenopausal women.
Colacurci N; Fornaro F; Cobellis L; De Franciscis P; Torella M; Sepe E; Arciello A; Cacciapuoti F; Paolisso G; Manzella D
Menopause; 2007; 14(5):879-84. PubMed ID: 17667145
[TBL] [Abstract][Full Text] [Related]
3. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
4. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Koizumi A; Kanai H; Araki Y; Itoh T; Iwasaki T; Sawada Y; Saito Y; Kumakura H; Takayama Y; Kanda T; Murakami M; Sakamaki T; Kurabayashi M
Int Heart J; 2010 Jan; 51(1):60-7. PubMed ID: 20145354
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation of carotid intima-media thickness with raloxifene serum levels in osteoporosis.
Lušin TT; Mrhar A; Marc J; Trontelj J; Zavratnik A; Zegura B; Pfeifer M; Ostanek B
Wien Klin Wochenschr; 2014 Jul; 126(13-14):403-8. PubMed ID: 24842749
[TBL] [Abstract][Full Text] [Related]
6. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial.
Morii H; Ohashi Y; Taketani Y; Fukunaga M; Nakamura T; Itabashi A; Sarkar S; Harper K
Osteoporos Int; 2003 Oct; 14(10):793-800. PubMed ID: 12955333
[TBL] [Abstract][Full Text] [Related]
7. The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis.
Celiloglu M; Aydin Y; Balci P; Kolamaz T
Menopause; 2009; 16(4):689-93. PubMed ID: 19240658
[TBL] [Abstract][Full Text] [Related]
8. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.
Tremollieres FA; Cigagna F; Alquier C; Cauneille C; Pouilles J; Ribot C
Atherosclerosis; 2000 Nov; 153(1):81-8. PubMed ID: 11058702
[TBL] [Abstract][Full Text] [Related]
9. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
11. [What can we expect of raloxifene in the treatment of postmenopausal osteoporosis--views of a gynecologist].
Chmel R; Rob L; Strnad P
Ceska Gynekol; 2002 Jul; 67(4):187-91. PubMed ID: 12373918
[TBL] [Abstract][Full Text] [Related]
12. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.
Cauley JA; Norton L; Lippman ME; Eckert S; Krueger KA; Purdie DW; Farrerons J; Karasik A; Mellstrom D; Ng KW; Stepan JJ; Powles TJ; Morrow M; Costa A; Silfen SL; Walls EL; Schmitt H; Muchmore DB; Jordan VC; Ste-Marie LG
Breast Cancer Res Treat; 2001 Jan; 65(2):125-34. PubMed ID: 11261828
[TBL] [Abstract][Full Text] [Related]
13. Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal women.
Cox DA; Sarkar S; Harper K; Barrett-Connor E
Curr Med Res Opin; 2004 Jul; 20(7):1049-55. PubMed ID: 15265250
[TBL] [Abstract][Full Text] [Related]
14. Influence of tamoxifen on carotid intima-media thickness in postmenopausal women.
Simon T; Boutouyrie P; Simon JM; Laloux B; Tournigand C; Tropeano AI; Laurent S; Jaillon P
Circulation; 2002 Dec; 106(23):2925-9. PubMed ID: 12460873
[TBL] [Abstract][Full Text] [Related]
15. Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study.
Takeuchi Y; Hamaya E; Taketsuna M; Sowa H
Menopause; 2015 Oct; 22(10):1134-7. PubMed ID: 25756692
[TBL] [Abstract][Full Text] [Related]
16. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
Cranney A; Adachi JD
Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357
[TBL] [Abstract][Full Text] [Related]
17. [Results of international clinical trials with raloxifene].
Agnusdei D; Liu-Léage S; Augendre-Ferrante B
Ann Endocrinol (Paris); 1999 Sep; 60(3):242-6. PubMed ID: 10520416
[TBL] [Abstract][Full Text] [Related]
18. Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes.
Barrett-Connor E; Ensrud KE; Harper K; Mason TM; Sashegyi A; Krueger KA; Anderson PW
Clin Ther; 2003 Mar; 25(3):919-30. PubMed ID: 12852708
[TBL] [Abstract][Full Text] [Related]
19. The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
Hayashi T; Ina K; Maeda M; Nomura H
Nitric Oxide; 2011 May; 24(4):199-203. PubMed ID: 21513812
[TBL] [Abstract][Full Text] [Related]
20. Long-term hormone replacement therapy delays the age related progression of carotid intima-media thickness in healthy postmenopausal women.
Takahashi K; Tanaka E; Murakami M; Mori-Abe A; Kawagoe J; Takata K; Ohmichi M; Kurachi H
Maturitas; 2004 Oct; 49(2):170-7. PubMed ID: 15474762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
